MD3771G2 - Inhibitori ai enzimei 17β-HSD, stimulatoare a multiplicării celulelor cancerului prostatei - Google Patents

Inhibitori ai enzimei 17β-HSD, stimulatoare a multiplicării celulelor cancerului prostatei

Info

Publication number
MD3771G2
MD3771G2 MDA20080118A MD20080118A MD3771G2 MD 3771 G2 MD3771 G2 MD 3771G2 MD A20080118 A MDA20080118 A MD A20080118A MD 20080118 A MD20080118 A MD 20080118A MD 3771 G2 MD3771 G2 MD 3771G2
Authority
MD
Moldova
Prior art keywords
prostate cancer
stimulator
inhibitors
cancer cell
cell multiplication
Prior art date
Application number
MDA20080118A
Other languages
English (en)
Russian (ru)
Other versions
MD3771F1 (ro
Inventor
Аурелиан ГУЛЯ
Дональд ПОЙРИЕР
Дженни РОЙ
Виктор ЦАПКОВ
Original Assignee
Государственный Университет Молд0
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Университет Молд0 filed Critical Государственный Университет Молд0
Priority to MDA20080118A priority Critical patent/MD3771G2/ro
Publication of MD3771F1 publication Critical patent/MD3771F1/ro
Publication of MD3771G2 publication Critical patent/MD3771G2/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Invenţia se referă la chimie, şi anume la compuşii organici din clasa tiosemicarbazonelor, care pot fi utilizaţi pentru tratamentul cancerului prostatei.Esenţa invenţiei constă în utilizarea 4-feniltiosemicarbazonelor aldehidelor salicilice şi 2-hidroxi-1-naftoice în calitate de inhibitori ai enzimei 17β-HSD (hidroxisteroid dehidrogenază), stimulatoare a multiplicării celulelor cancerului prostatei.
MDA20080118A 2008-04-30 2008-04-30 Inhibitori ai enzimei 17β-HSD, stimulatoare a multiplicării celulelor cancerului prostatei MD3771G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20080118A MD3771G2 (ro) 2008-04-30 2008-04-30 Inhibitori ai enzimei 17β-HSD, stimulatoare a multiplicării celulelor cancerului prostatei

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20080118A MD3771G2 (ro) 2008-04-30 2008-04-30 Inhibitori ai enzimei 17β-HSD, stimulatoare a multiplicării celulelor cancerului prostatei

Publications (2)

Publication Number Publication Date
MD3771F1 MD3771F1 (ro) 2008-12-31
MD3771G2 true MD3771G2 (ro) 2009-07-31

Family

ID=40255075

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20080118A MD3771G2 (ro) 2008-04-30 2008-04-30 Inhibitori ai enzimei 17β-HSD, stimulatoare a multiplicării celulelor cancerului prostatei

Country Status (1)

Country Link
MD (1) MD3771G2 (ro)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3996C2 (ro) * 2009-05-25 2010-07-31 Государственный Университет Молд0 Percloraţi de 5-R-saliciliden-4-feniltiosemicarbazonato(1-)-aquacupru(II) ce posedă proprietăţi de inhibitori ai activităţii enzimei 17 b-HSD (tipul 1)
MD4025C2 (ro) * 2009-08-25 2010-10-31 Владимир КАРАУШ Remediu pentru tratamentul prostatitei şi hiperplaziei prostatei
MD4126C1 (ro) * 2010-11-15 2012-04-30 Государственный Университет Молд0 N,N'-[4,4'-(perfluoro-1,4-fenilendioxi)-bis(4,1-fenilen)]-bis[2-(piridin-2-ilmetilen)hidrazincarbotioamidă] şi utilizarea ei în calitate de inhibitor al proliferării celulelor LNCaP ale cancerului prostatei
MD4132C1 (ro) * 2010-12-13 2012-05-31 Государственный Университет Молд0 Di(µ-S)-bis{cloro-[fenil(piridin-2-il)metanon-tiosemicarbazonato(1-)]cupru} care manifestă proprietatea de inhibare a proliferării celulelor T-47D ale cancerului mamar
MD4349C1 (ro) * 2014-06-23 2015-12-31 Государственный Университет Молд0 Compusul N-(3-metoxifenil)-2-(piridin-2-ilmetilen)-hidrazincarbotioamidă - inhibitor al proliferării celulelor MeW-164 ale melanomului uman

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Горбунова В. А. Новые цитостатики в лечении злокачественных *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3996C2 (ro) * 2009-05-25 2010-07-31 Государственный Университет Молд0 Percloraţi de 5-R-saliciliden-4-feniltiosemicarbazonato(1-)-aquacupru(II) ce posedă proprietăţi de inhibitori ai activităţii enzimei 17 b-HSD (tipul 1)
MD4025C2 (ro) * 2009-08-25 2010-10-31 Владимир КАРАУШ Remediu pentru tratamentul prostatitei şi hiperplaziei prostatei
MD4126C1 (ro) * 2010-11-15 2012-04-30 Государственный Университет Молд0 N,N'-[4,4'-(perfluoro-1,4-fenilendioxi)-bis(4,1-fenilen)]-bis[2-(piridin-2-ilmetilen)hidrazincarbotioamidă] şi utilizarea ei în calitate de inhibitor al proliferării celulelor LNCaP ale cancerului prostatei
MD4132C1 (ro) * 2010-12-13 2012-05-31 Государственный Университет Молд0 Di(µ-S)-bis{cloro-[fenil(piridin-2-il)metanon-tiosemicarbazonato(1-)]cupru} care manifestă proprietatea de inhibare a proliferării celulelor T-47D ale cancerului mamar
MD4349C1 (ro) * 2014-06-23 2015-12-31 Государственный Университет Молд0 Compusul N-(3-metoxifenil)-2-(piridin-2-ilmetilen)-hidrazincarbotioamidă - inhibitor al proliferării celulelor MeW-164 ale melanomului uman

Also Published As

Publication number Publication date
MD3771F1 (ro) 2008-12-31

Similar Documents

Publication Publication Date Title
MY160399A (en) Compounds, compositions, and methods for preventing metastasis of cancer cells
MX2010009765A (es) Moleculas pequeñas que contienen boro como agentes anti-inflamatorios.
PH12014502258A1 (en) Treatment of pluripotent cells
WO2012037155A3 (en) Tyrosine kinase inhibitors
WO2012018404A3 (en) Use of her3 binding agents in prostate treatment
MY163477A (en) Pyrimidinyl-pyridazinone derivatives
EA201170288A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
WO2009111676A8 (en) Boron-containing small molecules as anti-inflammatory agents
MX342128B (es) Compuestos farmaceuticos.
TW200640936A (en) Proteasome inhibitors and methods of using the same
MX2010010317A (es) Compuestos heterociclicos novedosos y usos de los mismos.
MX2011006290A (es) Compuestos de aza-azuleno.
MX354402B (es) Inhibidores de molecula pequeña del dominio de homologia de pleckstrin y metodos para usar los mismos.
MY173998A (en) Glucosylceramide synthase inhibitors
WO2009031040A3 (en) Compounds with anti-cancer activity
MX366318B (es) Derivados de aminas heterocíclicas que inhiben la transducción de señal mediana por cinasa asociada con el receptor de interleucina-1.
PH12014501639A1 (en) Pharmaceutical compositions and methods
EA201100125A1 (ru) Производные пирролопиридинилпиримидин-2-иламина
WO2009126786A3 (en) Improved quenching methods for red blood cell pathogen inactivation
IL207310A0 (en) Vaccine compositions
MX2015001551A (es) Compuestos y composiciones activadoras de enzima.
WO2009114703A3 (en) Combination therapy for the treatment of cancer
MX336022B (es) Activadores de pkm2 bicíclicos.
WO2010019775A3 (en) Methods of treating ras driven cancer in a subject
WO2010132622A3 (en) Anticd20-cpg conjugates and methods of treating b cell malignancies

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees